| |
| |
|
| Insider
Information: |
Scangos George A |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
934,251 |
|
|
Indirect Shares
|
3,765,803 |
|
|
| Direct
Value |
$30,246,957 |
|
|
|
Indirect Value
|
$5,264,656 |
|
|
| Total
Shares |
4,700,054 |
|
|
| Total
Value |
$35,511,613 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Exelixis Inc |
EXEL |
Director |
2020-05-18 |
714,717 |
2020-05-18 |
23,595 |
Premium* |
|
|
Anadys Pharmaceuticals Inc |
ANDS |
Director |
2008-08-26 |
33,188 |
2004-03-31 |
0 |
Premium* |
|
|
Biogen Idec Inc |
BIIB |
Chief Executive Office... |
2016-07-21 |
54,779 |
2016-07-21 |
10,756 |
Premium* |
|
|
Agilent Technologies Inc |
A |
Director |
2024-05-29 |
18,578 |
2024-05-29 |
17,893 |
Premium* |
|
|
Vir Biotechnology, Inc. |
VIR |
Director |
2024-02-26 |
112,989 |
2024-02-26 |
3,713,559 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
378 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 16
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2015-02-09 |
4 |
D |
$396.88 |
$1,960,587 |
D/D |
(4,940) |
24,315 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2014-04-01 |
4 |
AS |
$308.42 |
$654,776 |
D/D |
(2,123) |
26,142 |
0 |
- |
|
| A |
Agilent Technologies Inc |
Director |
• • – |
2020-04-17 |
4 |
A |
$73.01 |
$299,921 |
D/D |
4,108 |
27,887 |
0 |
- |
|
| A |
Agilent Technologies Inc |
Director |
• • – |
2020-08-03 |
4 |
A |
$93.91 |
$16,622 |
D/D |
177 |
28,112 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2014-03-10 |
4 |
AS |
$327.76 |
$8,719,378 |
D/D |
(26,124) |
28,265 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2015-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,270 |
29,255 |
0 |
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
Director |
– • – |
2008-08-26 |
4 |
B |
$2.70 |
$27,000 |
D/D |
10,000 |
33,188 |
2.39 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2015-02-10 |
4 |
D |
$395.13 |
$3,505,198 |
D/D |
(8,871) |
34,277 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2014-07-15 |
4 |
D |
$312.00 |
$3,139,344 |
D/D |
(10,062) |
34,812 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2013-11-01 |
4 |
AS |
$245.57 |
$549,831 |
D/D |
(2,239) |
39,044 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2012-11-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,756 |
40,914 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2015-06-01 |
4 |
AS |
$398.87 |
$543,261 |
D/D |
(1,362) |
41,090 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2013-10-01 |
4 |
AS |
$242.85 |
$543,741 |
D/D |
(2,239) |
41,283 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2015-05-01 |
4 |
AS |
$377.52 |
$514,182 |
D/D |
(1,362) |
42,452 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2015-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,833 |
43,148 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2015-02-12 |
4/A |
OE |
$0.00 |
$0 |
D/D |
9,189 |
43,466 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2013-09-03 |
4 |
AS |
$213.30 |
$480,042 |
D/D |
(2,239) |
43,522 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2015-04-01 |
4 |
AS |
$423.20 |
$576,398 |
D/D |
(1,362) |
43,814 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2014-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,339 |
44,874 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2015-03-13 |
4 |
AS |
$412.69 |
$221,613 |
D/D |
(537) |
45,176 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2014-02-09 |
4 |
D |
$315.54 |
$1,530,369 |
D/D |
(4,850) |
45,464 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2015-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,599 |
45,547 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2015-03-02 |
4 |
AS |
$410.67 |
$338,803 |
D/D |
(825) |
45,713 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2013-08-01 |
4 |
AS |
$218.82 |
$489,938 |
D/D |
(2,239) |
45,761 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2015-02-19 |
4 |
AS |
$401.04 |
$215,358 |
D/D |
(537) |
46,538 |
0 |
- |
|
378 Records found
|
|
Page 2 of 16 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
